Search

Your search keyword '"Ekaterina, Rogaeva"' showing total 370 results

Search Constraints

Start Over You searched for: Author "Ekaterina, Rogaeva" Remove constraint Author: "Ekaterina, Rogaeva"
370 results on '"Ekaterina, Rogaeva"'

Search Results

1. Corrigendum to: 'Generation of five induced pluripotent stem cells lines from four members of the same family carrying a C9orf72 repeat expansion and one wild-type member' [Stem Cell Res. 66 (2023) 1–5/102998]

2. Early neurotransmitters changes in prodromal frontotemporal dementia: A GENFI study

3. Letter to the editor on a paper by Kaivola et al. (2020): carriership of two copies of C9orf72 hexanucleotide repeat intermediate-length alleles is not associated with amyotrophic lateral sclerosis or frontotemporal dementia

4. Generation of five induced pluripotent stem cells lines from four members of the same family carrying a C9orf72 repeat expansion and one wild-type member

5. Establishing an online resource to facilitate global collaboration and inclusion of underrepresented populations: Experience from the MJFF Global Genetic Parkinson's Disease Project.

6. Contribution of rare variant associations to neurodegenerative disease presentation

7. White matter hyperintensities in autopsy-confirmed frontotemporal lobar degeneration and Alzheimer’s disease

8. Targeted copy number variant identification across the neurodegenerative disease spectrum

9. Combined epigenetic/genetic study identified an ALS age of onset modifier

10. Genetic and Epigenetic Study of Monozygotic Twins Affected by Parkinson’s Disease

11. Analysis of neurodegenerative disease-causing genes in dementia with Lewy bodies

12. Heritability and genetic variance of dementia with Lewy bodies

13. Disease-related cortical thinning in presymptomatic granulin mutation carriers

14. Differential early subcortical involvement in genetic FTD within the GENFI cohort

15. The Intersection between COVID-19, the Gene Family of ACE2 and Alzheimer’s Disease

16. DNA Methylation Clocks and Their Predictive Capacity for Aging Phenotypes and Healthspan

17. Interaction of APOE4 alleles and PET tau imaging in former contact sport athletes

18. A complex of C9ORF72 and p62 uses arginine methylation to eliminate stress granules by autophagy

19. The relationship between brain atrophy and cognitive-behavioural symptoms in retired Canadian football players with multiple concussions

20. Clinical and neuropathological features of ALS/FTD with TIA1 mutations

21. White matter hyperintensities are seen only in GRN mutation carriers in the GENFI cohort

22. Epigenetic Clock Acceleration Is Linked to Age at Onset of Parkinson's Disease

23. Epigenetic clock acceleration is linked to earlier onset and phenoconversion age in REM sleep behavior disorder

24. <scp>MicroRNA</scp> ‐128 suppresses tau phosphorylation and reduces amyloid‐beta accumulation by inhibiting the expression of <scp>GSK3β</scp> , <scp>APPBP2</scp> , and <scp>mTOR</scp> in Alzheimer's disease

25. A data-driven disease progression model of fluid biomarkers in genetic frontotemporal dementia

26. Protracted course progressive supranuclear palsy

27. New insights into the genetic etiology of Alzheimer's disease and related dementias

28. Case of a Man with Hemichorea and Behavioral Changes: 'A Red Herring'

29. Characteristics of the Ontario Neurodegenerative Disease Research Initiative cohort

30. Marked Differences in C9orf72 Methylation Status and Isoform Expression between C9/ALS Human Embryonic and Induced Pluripotent Stem Cells

31. Mendelian Randomisation Study of Smoking, Alcohol, and Coffee Drinking in Relation to Parkinson’s Disease

32. Axial Impairment Following Deep Brain Stimulation in Parkinson’s Disease: A Surgicogenomic Approach

33. The Rossy Progressive Supranuclear Palsy Centre: creation and initial experience

34. Genome-wide structural variant analysis identifies risk loci for non-Alzheimer's dementias

35. Soluble Epoxide Hydrolase Derived Linoleic Acid Oxylipins, Small Vessel Disease Markers, and Neurodegeneration in Stroke

36. Identification of a sex-specific genetic signature in dementia with Lewy bodies: a meta-analysis of genome-wide association studies

37. Generation of five induced pluripotent stem cells lines from four members of the same family carrying a C9orf72 repeat expansion and one wild-type member

38. Amyloid-β toxicity modulates tau phosphorylation through the PAX6 signalling pathway

39. Time-course global proteome analyses reveal an inverse correlation between Aβ burden and immunoglobulin M levels in the APPNL-F mouse model of Alzheimer disease.

41. Progressive Supranuclear Palsy Syndrome Associated With a Novel Tauopathy: Case Study

42. Combined epigenetic/genetic study identified an ALS age of onset modifier

43. Drug Repositioning for Alzheimer's Disease Based on Systematic 'omics' Data Mining.

44. Parkinson's Disease,<scp>NOTCH3</scp>Genetic Variants, and White Matter Hyperintensities

45. Social cognition impairment in genetic frontotemporal dementia within the GENFI cohort

46. CAPTURE ALS: the comprehensive analysis platform to understand, remedy and eliminate ALS

47. Epigenetic clock acceleration is linked to age-at-onset of idiopathic and LRRK2 Parkinson’s disease

48. A panel of CSF proteins separates genetic frontotemporal dementia from presymptomatic mutation carriers

49. Contribution of rare variant associations to neurodegenerative disease presentation

50. SLITRK2, an X-linked modifier of the age at onset in C9orf72 frontotemporal lobar degeneration

Catalog

Books, media, physical & digital resources